News | December 20, 2023
Asahi Kasei opens new Bioprocess Technical Center in China
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Five batches across four programs of Biocon Academy participated in the graduation ceremony
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Receives registration of Valganciclovir powder for oral solution in Germany
Leading USA based genetic testing brand officially enters the Indian market
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Subscribe To Our Newsletter & Stay Updated
